Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia.

MLA

Tran, Nikki N., et al. “Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia.” Open Forum Infectious Diseases, vol. 10, no. 4, Mar. 2023, p. ofad170. EBSCOhost, https://doi.org/10.1093/ofid/ofad170.

APA

Tran, N. N., Mynatt, R. P., Kaye, K. S., Zhao, J. J., & Pogue, J. M. (2023). Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia. Open Forum Infectious Diseases, 10(4), ofad170. https://doi.org/10.1093/ofid/ofad170

Chicago

Tran, Nikki N, Ryan P Mynatt, Keith S Kaye, Jing J Zhao, and Jason M Pogue. 2023. “Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia.” Open Forum Infectious Diseases 10 (4): ofad170. doi:10.1093/ofid/ofad170.